Optomed Oyj (HEL: OPTOMED)
Finland
· Delayed Price · Currency is EUR 5.32
+0.06 (1.14%)
Aug 30, 2024, 6:29 PM EET
Optomed Oyj Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 14.71 | 15.1 | 14.66 | 14.85 | 13.01 | 14.98 | Upgrade
|
| Other Revenue | - | - | - | - | 0.16 | 0.25 | Upgrade
|
| Revenue | 14.71 | 15.1 | 14.66 | 14.85 | 13.17 | 15.23 | Upgrade
|
| Revenue Growth (YoY) | -1.51% | 3.00% | -1.28% | 12.77% | -13.54% | 11.81% | Upgrade
|
| Cost of Revenue | 4.74 | 4.86 | 5.45 | 5.1 | 4.21 | 5.29 | Upgrade
|
| Gross Profit | 9.97 | 10.24 | 9.21 | 9.75 | 8.96 | 9.94 | Upgrade
|
| Selling, General & Admin | 9.27 | 9.33 | 9.61 | 9.38 | 7.74 | 7.79 | Upgrade
|
| Other Operating Expenses | 3.31 | 2.69 | 2.39 | 2.91 | 1.95 | 2.49 | Upgrade
|
| Operating Expenses | 14.91 | 14.2 | 14.11 | 14.5 | 11.7 | 12.54 | Upgrade
|
| Operating Income | -4.94 | -3.95 | -4.9 | -4.75 | -2.75 | -2.6 | Upgrade
|
| Interest Expense | - | -0.2 | -0.12 | -0.1 | -0.17 | -0.37 | Upgrade
|
| Interest & Investment Income | 0.42 | 0.02 | 0 | 0.02 | 0.01 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.31 | -0.31 | -0.2 | 0.47 | -0.1 | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.08 | -0.05 | -0.15 | 0.07 | -0.08 | -0.01 | Upgrade
|
| EBT Excluding Unusual Items | -4.9 | -4.5 | -5.35 | -4.29 | -3.09 | -2.95 | Upgrade
|
| Asset Writedown | -0.02 | -0.02 | -1.04 | -0.57 | -0.16 | - | Upgrade
|
| Other Unusual Items | - | - | 0.84 | 0.54 | - | - | Upgrade
|
| Pretax Income | -4.92 | -4.52 | -5.55 | -4.33 | -3.25 | -2.95 | Upgrade
|
| Income Tax Expense | -0.07 | -0.08 | -0.08 | -0.08 | -0.07 | -0.08 | Upgrade
|
| Earnings From Continuing Operations | - | -4.44 | -5.47 | -4.25 | -3.18 | -2.88 | Upgrade
|
| Net Income to Company | - | -4.44 | -5.47 | -4.25 | -3.18 | -2.88 | Upgrade
|
| Net Income | -4.85 | -4.44 | -5.47 | -4.25 | -3.18 | -2.88 | Upgrade
|
| Net Income to Common | -4.85 | -4.44 | -5.47 | -4.25 | -3.18 | -2.88 | Upgrade
|
| Shares Outstanding (Basic) | 18 | 17 | 15 | 13 | 13 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 18 | 17 | 15 | 13 | 13 | 9 | Upgrade
|
| Shares Change (YoY) | 13.01% | 14.11% | 8.92% | 1.35% | 48.43% | 14.92% | Upgrade
|
| EPS (Basic) | -0.28 | -0.27 | -0.37 | -0.32 | -0.24 | -0.32 | Upgrade
|
| EPS (Diluted) | -0.28 | -0.27 | -0.37 | -0.32 | -0.24 | -0.32 | Upgrade
|
| Free Cash Flow | -0.98 | -0.83 | -3.15 | -3.4 | -3.07 | -0.1 | Upgrade
|
| Free Cash Flow Per Share | -0.06 | -0.05 | -0.22 | -0.25 | -0.23 | -0.01 | Upgrade
|
| Gross Margin | 67.76% | 67.83% | 62.83% | 65.64% | 68.01% | 65.29% | Upgrade
|
| Operating Margin | -33.56% | -26.18% | -33.41% | -31.97% | -20.85% | -17.04% | Upgrade
|
| Profit Margin | -32.99% | -29.41% | -37.33% | -28.61% | -24.13% | -18.88% | Upgrade
|
| Free Cash Flow Margin | -6.67% | -5.48% | -21.49% | -22.91% | -23.31% | -0.65% | Upgrade
|
| EBITDA | -4.19 | -3.21 | -4.12 | -3.99 | -1.98 | -1.57 | Upgrade
|
| EBITDA Margin | -28.47% | -21.25% | -28.10% | -26.87% | -15.04% | -10.30% | Upgrade
|
| D&A For EBITDA | 0.75 | 0.74 | 0.78 | 0.76 | 0.77 | 1.03 | Upgrade
|
| EBIT | -4.94 | -3.95 | -4.9 | -4.75 | -2.75 | -2.6 | Upgrade
|
| EBIT Margin | -33.56% | -26.18% | -33.41% | -31.97% | -20.85% | -17.04% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.